Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Post-Paclitaxel: Will Boston Scientific Cut Guidant Royalty Deal?
Jun 24 2002
More from Archive
More from Medtech Insight